Moreover, work in human and AD mouse models has shown that these genes (i.e. Trem2) can play conflicting roles, protective or detrimental, depending on the stage of disease development and progression, making it critical to understand the specific time-dependent roles in effects of risk variants in AD [144]. Here, TREM2 is linked to Alzheimer disease.